Transmucosal delivery systems for calcitonin: a review
Source abstract
Abstract
The commercial availability of peptides and proteins and their advantages as therapeutic agents have been the basis for tremendous efforts in designing delivery systems for such agents. The protection of these agents from biological fluids and physiological interactions is crucial for the treatment efficacy. One such agent is salmon calcitonin, a 32 amino-acid polypeptide hormone used in the treatment of bone diseases such as Paget's disease, hypercalcemia and osteoporosis. Researchers have studied different routes to deliver salmon calcitonin more effectively, including nasal, oral, vaginal and rectal delivery. These systems are designed to protect the polypeptide from the biological barriers that each delivery route imposes. Oil-based and polymer-based delivery systems are discussed.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Protein purification and stability · Proteins in Food Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways10.1023/A:1011908128045 ↗
2. Improving protein therapeutics with sustained-release formulations10.1038/nbt0298-153 ↗
3. Degradation pathways. Analytical characterization and formulation strategies of a peptide and protein calcitonin and human growth hormone in comparison10.1016/S0031-6865(96)00049-0 ↗
4. Degradation pathways of salmon calcitonin in aqueous solution10.1021/js9602305 ↗
5. Chemistry of calcitonins10.1016/0169-6009(92)90894-J ↗
6. A new route of drug administration: intrauterine delivery of insulin and calcitonin10.1023/A:1018948924992 ↗
7. Intrauterine administration of peptide drugs for systemic effect10.1016/0169-409X(95)00086-M ↗
8. Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats10.1016/0378-5173(94)00226-U ↗
9. Novel vaginal delivery systems for calcitonin: II. Preparation and characterization of HYAFF microspheres containing calcitonin10.1016/S0378-5173(96)04686-8 ↗
10. Biodegradable microspheres as depot for parenteral delivery of peptide drugs10.1016/0168-3659(94)90082-5 ↗
11. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres10.1016/0168-3659(91)90059-M ↗
12. Effect of solvent removal technique on the matrix characteristics of poly(lactic/glycolide) microspheres for peptide delivery10.1016/0168-3659(95)00125-5 ↗
13. Adsorption of salmon calcitonin to PLGA microspheres10.1023/A:1016278902839 ↗
14. Properties if a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods10.1016/S0939-6411(97)00121-5 ↗
15. Labelling peptides with fluorescent probes for incorporation into degradable polymers10.1016/S0939-6411(98)00009-5 ↗
16. Chitosan beads for the delivery of salmon calcitonin: preparation and release characteristics10.1016/0378-5173(95)04300-4 ↗
17. Calcitonin and insulin in isobutyl cyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats10.1111/j.2042-7158.1994.tb03854.x ↗
18. Effects of poly(acrylic) polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin10.1111/j.2042-7158.1996.tb05869.x ↗
19. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin10.1023/A:1016213405081 ↗
20. Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions10.1016/S0378-5173(97)00140-3 ↗
21. Temperature and pH-sensitive polymers for human calcitonin delivery10.1023/A:1016026711364 ↗
22. Stabilization of salmon calcitonin by poly(styrene) nanoparticles having surface hydrophilic polymeric chains, against enzymatic degradation10.1016/S0378-5173(97)00284-6 ↗
23. Absorption enhancement of orally administred salmon calcitonin by poly(styrene) nanoparticles having poly(N-isopropylacrylamide) branches on their surfaces10.1016/S0378-5173(97)00247-0 ↗
24. Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches10.1016/S0378-5173(96)04861-2 ↗
25. Novel pH-sentive hydrogels for the oral delivery of calcitonin10.1021/ma990541c ↗
26. Flynn, M. Oral delivery of insulin and calcitonin in humans. IBC third Annual International Conference of Delivery of Peptides and Proteins. Coronado, California, 1997.
27. Solubilization of hydrophilic drugs in oily formulation10.1016/S0169-409X(96)00491-7 ↗
28. Peptide hormones: review of current and emerging uses by nasal delivery10.1016/S0169-409X(97)00062-8 ↗